Skip to content
Open access

Evaluation of the Diagnostic and Prognostic Potential, and Correlation with the Tumor Immune Microenvironment of a Six-miRNA Signature Associated with Platinum Sensitivity in Patients with Early-Stage Non-Small-Cell Lung Cancer

Oct 2026 · Cancers · Vol 18 · 0 citations · 75 references
Medicine

Abstract

Simple Summary Patients with non-small-cell lung cancer can respond differently to platinum-based chemotherapy, highlighting the need for reliable biomarkers that can help predict disease outcomes and support treatment decisions. In this study, we evaluated a panel of six small RNA molecules, called microRNAs, in tumor tissue and blood plasma from patients with surgically treated NSCLC who received platinum-based chemotherapy. The six-microRNA signature showed the ability to distinguish tumor from normal lung tissue and was associated with relapse-free survival. The microRNAs were also detectable in plasma, supporting their potential use as minimally invasive blood-based biomarkers. In addition, associations between specific microRNAs and immune-related markers within the tumor were identified, suggesting a possible link between the signature and the tumor immune environment. These findings support further investigation of this six-microRNA signature as a potential tool for patient stratification and outcome prediction in NSCLC.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.